Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
University Hospital Southampton NHS Foundation Trust (UHS) is a leading teaching hospital and research hub in the United Kingdom, providing specialist services to over 3.7 million people across the south of England. As a major center for clinical innovation, it hosts the NIHR Southampton Biomedical Research Centre and a dedicated Clinical Research Facility in partnership with the University of Southampton. The Trust is internationally recognized for its expertise in oncology, respiratory medicine, cardiovascular health, and pediatrics. UHS plays a pivotal role in the global life sciences ecosystem by leading and hosting hundreds of clinical trials ranging from Phase 1 to Phase 3. Its integrated approach combines world-class patient care with cutting-edge research into new therapeutic modalities such as mRNA vaccines and cell therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on University Hospital Southampton NHS Foundation Trust.